- emergers.se - Page 8

SIMRIS ALG: Cyano deal jumpstarts venture into Biopharma | See interview with CEO Julian Read

2022-09-07• Analys

With the successful completion of the acquisition of Berlin-based Cyano Biotech GmbH, Simris Alg is now set to accelerate their entry into...

Read More →

BONZUN: Set to refuel to latch on to global DTx trend

2022-09-02• Analys

The Q2’22 report showed some continued progress for Bonzun’s stress management service, Bonzun Evolve, with 450 new licenses from KTH...

Read More →

QLUCORE: CE headwind overshadows structural growth story

2022-09-01• Analys, Research

While the business side of Qlucore is moving steady forward, with 67% growth, two new Qlucore Insight license deals and an expansion of the...

Read More →

KEBNI: Strong momentum with near-term triggers to crystalise further upside potential

2022-08-30• Analys

Besides completing a capital raise in these challenging market conditions, KebNi enjoys strong business momentum with new antenna orders...

Read More →

DLABORATORY: Welcome boost from booming attention on power grid stability

2022-08-26• Analys

The rise of network stability and electricity security on the public agenda has finally started to translate into a material rise in...

Read More →

SIMRIS ALG: Accelerating entry into high-value BioPharma with acquisition of Cyano Biotech

2022-08-18• Analys

In line with their strategic plan to move into the highest margin application areas, Simris Alg announced an LOI to acquire Cyano Biotech...

Read More →

GRANGEX: Progress and project improvement against prolonged favorable macro backdrop

2022-08-10• Analys, Research

As a result of the ongoing preparations of the DFS for Dannemora, GRANGEX now reports an upwards revision of the known and indicated...

Read More →

SIMRIS ALG: Targeting biopharma to exploit highest value verticals in the microalgae and cyanobacteria space

2022-08-05• Analys

With the new CEO in place, Simris has now set course to pursue the most high value application area for microalgae, the biopharma sector in...

Read More →

NANEXA: New facility important step in scaling up activity with eventful year ahead

2022-06-13• Analys, Research

Johan Widmark | 2022-06-13 08:00 READ FULL REPORT HERE IN PDF New facility up and running While the inauguration of Nanexa’s new...

Read More →

QLUCORE | Intervju med vd Carl-Johan Ivarsson om utsikterna för Diagnostics och intäktsmålet på 300 MSEK 2026

2022-06-02• Okategoriserade

Med en försäljningstillväxt på 9% under 2021/22 (Maj-April) ligger fokus på Qlucore nu på CE-märkningen av Diagnosticsplattformen...

Read More →

Författare: johan@emergers.se

SIMRIS ALG: Cyano deal jumpstarts venture into Biopharma | See interview with CEO Julian Read

BONZUN: Set to refuel to latch on to global DTx trend

QLUCORE: CE headwind overshadows structural growth story

KEBNI: Strong momentum with near-term triggers to crystalise further upside potential

DLABORATORY: Welcome boost from booming attention on power grid stability

SIMRIS ALG: Accelerating entry into high-value BioPharma with acquisition of Cyano Biotech

GRANGEX: Progress and project improvement against prolonged favorable macro backdrop

SIMRIS ALG: Targeting biopharma to exploit highest value verticals in the microalgae and cyanobacteria space

NANEXA: New facility important step in scaling up activity with eventful year ahead

QLUCORE | Intervju med vd Carl-Johan Ivarsson om utsikterna för Diagnostics och intäktsmålet på 300 MSEK 2026

Widmark Research

CONTACT